Stockreport

Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference [Yahoo! Finance]

Annovis Bio, Inc.  (ANVS) 
PDF clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkins [Read more]